OLUFUNMILAYO ILORI: Open Payments
NPI 1700142445 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,439 in 58 payments from 8 companies in 2025. Trend: 2023 $35,499 · 2024 $16,454 · 2025 $6,439
Speaker / faculty: $4,954Food & beverage: $1,376Education: $109
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $2,766 |
| ABBVIE INC. | 10 | $2,674 |
| E.R. Squibb & Sons, L.L.C. | 8 | $350 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $332 |
| Teva Pharmaceuticals USA, Inc. | 8 | $217 |
| Bausch Health US, LLC | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: ABILIFY MAINTENA, VRAYLAR, COBENFY, CAPLYTA, UZEDY, ABILIFY ASIMTUFII, APLENZIN, TRINTELLIX.
Industry payments across NJ — which companies pay providers there.
